HM04675 | CABP4 | eye | MESH:D001862 | Bone Resorption | |
HM04675 | CABP4 | eye | MESH:D014591 | Uterine Diseases | uterus |
HM04675 | CABP4 | eye | MESH:D014591 | Uterine Diseases | placenta |
HM04675 | CABP4 | eye | MESH:D014591 | Uterine Diseases | cervix |
HM04675 | CABP4 | eye | MESH:D002278 | Carcinoma in Situ | |
HM04675 | CABP4 | eye | MESH:D002278 | Carcinoma in Situ | |
HM04675 | CABP4 | eye | MESH:D011297 | Prenatal Exposure Delayed Effects | |
HM04675 | CABP4 | eye | MESH:D019966 | Substance-Related Disorders | |
HM04675 | CABP4 | eye | MESH:D011629 | Puberty, Precocious | |
HM04675 | CABP4 | eye | MESH:D011471 | Prostatic Neoplasms | prostate |
HM04675 | CABP4 | eye | MESH:D000860 | Anoxia | |
HM04675 | CABP4 | eye | MESH:D007333 | Insulin Resistance | |
HM04675 | CABP4 | eye | OMIM:610427 | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B | |
HM04675 | CABP4 | eye | MESH:D006527 | Hepatolenticular Degeneration | liver |
HM04675 | CABP4 | eye | MESH:D007022 | Hypotension | |
HM04675 | CABP4 | eye | MESH:D000138 | Acidosis | |
HM04675 | CABP4 | eye | MESH:D001943 | Breast Neoplasms | breast |
HM04675 | CABP4 | eye | MESH:D010049 | Ovarian Diseases | ovary |
HM04675 | CABP4 | eye | MESH:D009421 | Nervous System Malformations | |